口腔薄膜市场规模、份额、成长分析（按产品、适应症、分销管道和地区）- 产业预测，2025-2032 年

2023 年全球口腔薄膜市场规模为 34.6 亿美元，预计将从 2024 年的 37.8 亿美元成长到 2032 年的 77 亿美元，预测期间（2025-2032 年）的复合年增长率为 9.3%。

全球口腔薄膜市场已成为製药业的关键领域，其特点是生产可溶解的条带，以增强口服药物传输。这些薄膜提供了一种方便的、以患者为中心的传统锭剂和胶囊的替代品，提高了给药的简易性、剂量的准确性和患者的依从性，特别是对于儿科和老年人群。虽然对创新药物输送系统的需求正在推动市场成长，但复杂的製造流程、监管障碍以及来自既定剂型的竞争等挑战仍然存在。然而，机会无所不在，包括个人化医疗、儿科护理、自我管理疗法和营养保健品等应用领域的不断扩大，使口腔薄膜成为不断发展的医疗保健领域的关键参与者。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术进步

口腔薄膜市场按产品分類的规模

• 市场概况
• 舌下含片
• 即溶牙科/口腔膜

口腔薄膜市场规模（依适应症划分）

• 市场概况
• 思觉失调症
• 偏头痛
• 阿片类成瘾
• 噁心和呕吐
• 其他的

口腔薄膜市场规模（依分销通路划分）

• 市场概况
• 医院药房
• 零售药局
• 网路药局

口腔薄膜市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Pfizer Inc.（USA）
• Novartis International AG（Switzerland）
• Merck & Co., Inc.（USA）
• Sanofi SA（France）
• GlaxoSmithKline plc（UK）
• Johnson & Johnson（USA）
• Bayer AG（Germany）
• Eli Lilly and Company（USA）
• AbbVie Inc.（USA）
• AstraZeneca plc（UK）
• Sumitomo Dainippon Pharma Co., Ltd.（Japan）
• Indivior PLC（UK）
• BioDelivery Sciences International, Inc.（USA）
• Aquestive Therapeutics, Inc.（USA）
• IntelGenx Technologies Corp.（Canada）
• Tesa Labtec GmbH（Germany）
• CURE Pharmaceutical Holding Corp.（USA）
• ZIM Laboratories Limited（India）
• NAL Pharma（UK）

结论和建议

Global Oral Thin Films Market size was valued at USD 3.46 billion in 2023 and is poised to grow from USD 3.78 billion in 2024 to USD 7.7 billion by 2032, growing at a CAGR of 9.3% during the forecast period (2025-2032).

The global oral thin films market is emerging as a vital area of the pharmaceutical industry, characterized by the production of dissolvable strips that enhance oral drug delivery. These films offer a convenient and patient-centric alternative to traditional tablets and capsules, improving ease of administration, accurate dosage, and patient compliance, particularly for pediatric and geriatric populations. While the demand for innovative drug delivery systems propels market growth, challenges such as the complex manufacturing processes, regulatory hurdles, and competition from established dosage forms persist. Nevertheless, opportunities abound in personalized medicine, pediatric needs, and self-administered therapies, as well as expanding applications in the nutraceutical sector, positioning oral thin films as a significant player in the evolving healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oral Thin Films market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oral Thin Films Market Segmental Analysis

Global Oral Thin Films Market is segmented by Product, Disease Indication, Distribution Channel and region. Based on Product, the market is segmented into Sublingual Film and Fast Dissolving Dental/Buccal Film. Based on Disease Indication, the market is segmented into Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oral Thin Films Market

A significant factor propelling the Global Oral Thin Films market is the rising patient preference for non-invasive drug delivery systems. In 2022, an increasing number of patients favored oral thin films over conventional oral medications like tablets and injections, appreciating their convenience and user-friendliness. The quick disintegration and ease of administration associated with these films enhance medication compliance, making them an attractive option for many. Additionally, the COVID-19 pandemic heightened awareness of safety in healthcare practices, further boosting the demand for non-invasive delivery methods. Consequently, the shift towards oral thin films as a preferred choice in medication delivery is becoming more pronounced.

Restraints in the Global Oral Thin Films Market

In 2022, one of the major obstacles impacting the global oral thin films market was the intricate manufacturing processes tied to these specialized dosage forms. The production and scaling of oral thin films necessitate advanced technology, specialized knowledge, and stringent quality assurance measures. This complexity not only raises manufacturing costs but also restricts the accessibility and affordability of oral thin films for consumers. As a result, these factors collectively pose challenges to market expansion, potentially stifling innovation and limiting the reach of these products in the healthcare sector. Consequently, addressing these manufacturing hurdles is crucial for fostering market growth.

Market Trends of the Global Oral Thin Films Market

The Global Oral Thin Films market is currently influenced by a notable trend characterized by the challenges posed by complex manufacturing processes. As of 2022, these intricate production requirements have emerged as a significant restraint, demanding advanced equipment and specialized expertise, thereby resulting in higher associated costs. This complexity hampers not only the scalability of oral thin films but also their affordability, potentially stunting market growth. Consequently, while there is a growing demand for innovative and convenient drug delivery systems, the barriers posed by manufacturing intricacies are prompting industry players to pursue technological advancements and streamlined processes to enhance production efficiency and market accessibility.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement

Global Oral Thin Films Market Size by Product & CAGR (2025-2032)

• Market Overview
• Sublingual Film
• Fast Dissolving Dental/Buccal Film

Global Oral Thin Films Market Size by Disease Indication & CAGR (2025-2032)

• Market Overview
• Schizophrenia
• Migraine
• Opioid Dependence
• Nausea & Vomiting
• Others

Global Oral Thin Films Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Oral Thin Films Market Size & CAGR (2025-2032)

• North America (Product, Disease Indication, Distribution Channel)
  • US
  • Canada
• Europe (Product, Disease Indication, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Disease Indication, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Disease Indication, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Disease Indication, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sumitomo Dainippon Pharma Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indivior PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioDelivery Sciences International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aquestive Therapeutics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IntelGenx Technologies Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tesa Labtec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CURE Pharmaceutical Holding Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZIM Laboratories Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NAL Pharma (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations